Apollo Ingredients Ltd

Apollo Ingredients Ltd

BBSE:APOLLOIN
86.00
INR
-1.35
(-1.55%)
1.98EPS
44.12P/E
908.82MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
138.63
10.11
- -
- -
- -
- -
61.49
64.85
33.56
- -
14.17
43.57
4.71
8.76
Basic EPS, GAAP
2.95
-0.19
-1.13
-1.3
-1.61
-1.71
2.29
2.98
0.9
-1.04
0.86
1.38
0.68
1.98
Free Cash Flow per Basic Share
0.21
-0.3
0.21
0.08
-0.03
-0.24
1.51
-0.6
0.08
1.76
20.89
-1.75
-2.79
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
30.09
29.9
28.77
22.25
20.64
18.93
13.02
16.01
16.91
15.87
16.73
18.11
6.72
- -
Tangible Book Value per Share
30.09
29.9
28.77
22.25
20.64
18.93
13.02
16.01
16.91
15.87
16.73
18.11
6.72
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
1
1
1
1
1
1
10
11
Sales/Revenue/Turnover
55
4
- -
- -
- -
- -
43
46
24
- -
10
31
49
96
Operating Margin (%)
1.23
-25.61
- -
- -
- -
- -
2.04
3
-1.38
- -
7.93
4.89
16.93
21.9
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
Net Income, GAAP
1
- -
- -
-1
-1
-1
2
2
1
-1
1
1
7
22
Effective Tax Rate (%)
29.89
- -
- -
- -
- -
- -
15.76
22.92
24.82
- -
26
26
25.7
- -
Profit Margin (%)
2.13
-1.86
- -
- -
- -
- -
3.73
4.6
2.69
- -
6.09
3.17
14.45
22.62
Working Capital
10
10
9
9
8
7
9
11
12
11
12
13
41
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
12
12
12
9
8
8
9
11
12
11
12
13
70
- -
Return on Invested Capital (%)
8.8
- -
- -
- -
- -
- -
8.89
10.31
-2.12
- -
5.07
7.49
14.81
- -
Return on Capital (%)
17.69
- -
- -
- -
- -
- -
19.32
20.55
5.48
- -
5.3
7.96
17.07
- -
Return on Common Equity (%)
10.32
-0.63
-3.84
-5.09
-7.51
-8.66
19.32
20.55
5.48
-6.33
5.3
7.93
17.14
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
- -
- -
909

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
43
- -
Cash, Cash Equivalents & STI
- -
36
- -
Accounts Receivable, Net
- -
6
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
2
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
46.58%
91.94%
446.53%
Free Cash Flow
450.85%
1,066.57%
2,264.03%
Net Income, GAAP
-4.22%
43.67%
626.33%
Sales/Revenue/Turnover
- -
- -
59.43%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
5
8
11
7
31
2026
6
6
28
10
49
2027
53
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.02
-2.74
1.92
2.32
1.38
2026
-1.53
0.02
0.83
0.06
0.68
2027
1.17
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Sector
Process industries
Industry
Agricultural commodities/Milling
Address
Thane India
Business
Apollo Ingredients Limited is an India-based commercial enterprise engaged in the trading, sourcing, and distribution of agricultural commodities, nutritional ingredients, and diversified healthcare solutions. Founded in 1980 and headquartered in Thane, Maharashtra, the company serves industrial food processors, nutraceutical manufacturers, and healthcare institutions across India and international markets. Apollo Ingredients Limited structures its commercial activities across specialty agricultural inputs, wellness ingredients, pharmaceuticals, and healthcare management consultancy. The company's portfolio of products and services comprises agricultural products such as soya de-oiled cakes, soybean meal, processed oilseeds, and edible vegetable oils; specialty wellness and functional food ingredients including botanical extracts, phytochemicals, food enzymes, and probiotic formulations; pharmaceutical formulations covering Ayurvedic, homeopathic, and allopathic medicines for domestic distribution, import, and export; and healthcare institutional services, encompassing the operation and management of hospitals, diagnostic centers, pathology laboratories, and wellness clinics, alongside turnkey hospital facility planning, clinical audit advisory, and medical manpower staffing solutions. In recent developments, the company executed a major corporate transformation and official name change from Indsoya Limited to Apollo Ingredients Limited in September 2023 to align its corporate identity with a strategic pivot toward high-value ingredients and life sciences. In addition, the company has broadened its statutory business scope to actively enter pharmaceutical manufacturing and healthcare infrastructure management, supported by ongoing leadership and board reorganizations designed to drive its expansion across the integrated food ingredients and healthcare services sectors.